Exploring the mechanism of Buxue Yimu Pill on hemorrhagic anemia through molecular docking, network pharmacology and experimental validation
XIONG Y, CAO XY, LIU BY, DAI YQ, ZHOU HJ, HE JJ, GONG Y, WU XW, TANG HB · Chinese Journal of Natural Medicines · 2021 December
DOI 10.1016/S1875-5364(21)60104-8
Objective
To determine the bioactive molecules and therapeutic mechanism of Buxue Yimu Pill (BYP) against hemorrhagic anemia.
Conclusions
In conclusion, based on molecular docking, network pharmacology and validation experiment results, the enriching blood effect of Buxue Yimu Pill (BYP) on hemorrhagic anemia may be associated with hematopoiesis, anti-inflammation, and immunity enhancement.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
